This article is a correction to:
The Potential Relationship Between Environmental Endocrine Disruptor Exposure and the Development of Endometriosis and Adenomyosis
Victoria R. Stephens1,2Jelonia T. Rumph1,3Sharareh Ameli1,2
Kaylon L. Bruner-Tran1Kevin G. Osteen1,2,4*- 1Department of Obstetrics and Gynecology, Women’s Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, TN, United States
- 2Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States
- 3Department of Microbiology and Immunology, Meharry Medical College, Nashville, TN, United States
- 4VA Tennessee Valley Healthcare System, Nashville, TN, United States
A Corrigendum on
The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis
by Stephens VR, Rumph JT, Ameli S, Bruner-Tran KL and Osteen KG (2022). Front. Physiol. 12:807685. doi: 10.3389/fphys.2021.807685
In the published article, there was an error in the Funding statement. The authors omitted the disclaimer, which is required by the U.S. EPA, from their Funding statement. The EPA grant number was also incomplete and was listed as “R839501.”
“This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM007628 (JR), Training Program in Environmental Toxicology under award number TOX T32 ES007028 (VS), Bill and Melinda Gates Foundation (KB-T and KO), and U.S. Environmental Protection Agency #R839501 (KB-T and KO), R01HD096147 (KB-T and KO).”
The correct Funding statement appears below.
“The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis” was developed under Assistance Agreement No. RD83950101 awarded by the U.S. Environmental Protection Agency to KO. It has not been formally reviewed by EPA. The views expressed in this document are solely those of VS, JR, SA, KB-T, and KO and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.”
The authors apologize for this errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Author disclaimer
The views expressed in this document are solely those of VS, JR, SA, KB-T, and KO and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.
Keywords: endometriosis, adenomyosis, environmental toxicants, endocrine disrupting chemical (EDC), inflammation
Citation: Stephens VR, Rumph JT, Ameli S, Bruner-Tran KL and Osteen KG (2023) Corrigendum: The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis. Front. Physiol. 14:1260961. doi: 10.3389/fphys.2023.1260961
Received: 18 July 2023; Accepted: 08 August 2023;
Published: 14 August 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Stephens, Rumph, Ameli, Bruner-Tran and Osteen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kevin G. Osteen, kevin.osteen@vumc.org